NCT06109779 2026-03-04
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
AstraZeneca
Phase 3 Active not recruiting
AstraZeneca
University Health Network, Toronto
University of Southern California
Lisata Therapeutics, Inc.
Universitätsklinikum Hamburg-Eppendorf